Physicians’ Education Resource® to Present Optimizing Outcomes Through Stem Cell Mobilization as a Satellite Symposium Adjunct to the Transplantation and Cellular Therapy Meetings (TCT)
CRANBURY, N.J.--(BUSINESS WIRE)--Jan 22, 2019--Physicians’ Education Resource ® (PER ® ), a leading resource for continuing medical education (CME), will host a CME-accredited activity, Optimizing Outcomes Through Stem Cell Mobilization: Applying Evidence to Patients With Multiple Myeloma and Non-Hodgkin Lymphoma, on Friday, Feb. 22, at the George R. Brown Convention Center in Houston, Texas. The educational program will be chaired by Shaji Kumar, M.D., professor of medicine, Mayo Clinic College of Medicine, and consultant, division of hematology, department of internal medicine, Mayo Clinic.
This activity is a satellite symposium held adjunct to the TCT (Transplantation and Cellular Therapy Meetings). Formerly the BMT Tandem Meetings, are the combined annual meetings of the American Society of Blood and Marrow Transplantation (ASBMT) and CIBMTR.
“We are excited to present this new CME-certified activity that incorporates recent clinical data to optimize individualized approaches for autologous stem cell transplantation mobilization among patients with hematologic malignancies,” said Phil Talamo, president of PER ®. “Attendees who participate in this symposium will learn how to personalize decision-making to optimize outcomes for their patients with hematologic malignancies.”
Faculty members for the educational activity include the following clinical experts:Sergio A. Giralt, M.D., FACP, chief, adult bone marrow transplant service, Melvin Berlin Family chair in multiple myeloma, Memorial Sloan Kettering Cancer Center. Paul J. Shaughnessy, M.D., director, adult blood and marrow stem cell transplant program, Methodist Physician Practices, and assistant professor of medicine, University of Texas Health Science Center.
This highly interactive educational CME program will address the rapidly evolving treatment landscape for hematologic malignancies such as multiple myeloma and non-Hodgkin lymphoma. Hematopoietic stem cell transplantation (HSCT) has remained a cornerstone approach for the management of many patients with these conditions, and techniques for optimal stem cell mobilization continue to be investigated, with the goals of minimizing the burden on the patient and maximizing the likelihood of successful stem cell collection for anticipated procedures.
During this exciting case-based format, Kumar along with Giralt and Shaughnessy will review the latest clinical data to help attendees apply the information effectively to the management of their patients who may be candidates for HSCT. Key decision points pertaining to transplantation and stem cell mobilization will also be reviewed in depth during the activity.
For more information and to register, click here.
About Physicians’ Education Resource ® (PER ® )
Since 1995, PER ® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER ® initiated CME programming in the cardiovascular and endocrinology areas. While continuing to expand into topics beyond oncology, PER ® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature distinguished experts who focus on the application of practice-changing advances. PER ® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER ® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005605/en/
CONTACT: PER® MediaContacts
Alexandra Ventura, 609-716-7777, ext. 121
firstname.lastname@example.orgJohn Patricolo, 609-325-4630
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: STEM CELLS HEALTH ONCOLOGY RESEARCH OTHER SCIENCE SCIENCE
SOURCE: Physicians’ Education Resource
Copyright Business Wire 2019.
PUB: 01/22/2019 10:01 AM/DISC: 01/22/2019 10:01 AM